Xact Kapitalforvaltning’s Haemonetics HAE Stock Holding History

Xact Kapitalforvaltning’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$886K	Hold	8,895	–	–	0.02%	535
2019 Q4	$1.02M	Hold	8,895	–	–	0.02%	605
2019 Q3	$1.12M	Sell	8,895 -600	-6%	-$76.2K	0.02%	537
2019 Q2	$1.14M	Hold	9,495	–	–	0.02%	529
2019 Q1	$831K	Hold	9,495	–	–	0.02%	655
2018 Q4	$950K	Buy	9,495 +900	+10%	+$94.5K	0.02%	565
2018 Q3	$985K	Buy	8,595 +1,100	+15%	+$114K	0.02%	591
2018 Q2	$672K	Buy	7,495 +200	+3%	+$16.9K	0.01%	752
2018 Q1	$534K	Buy	7,295 +2,000	+38%	+$137K	0.01%	792
2017 Q4	$308K	Buy	+5,295	New	+$279K	0.01%	935

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Xact Kapitalforvaltning's HAE Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Haemonetics (HAE) position steady in Q1 2020 at 8,895 shares worth $886K. The position accounts for 0.02% of the portfolio, ranked #535.

Xact Kapitalforvaltning first reported a position in HAE in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.14M in Q2 2019. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

Xact Kapitalforvaltning held 8,895 shares of Haemonetics worth $886K as of Q1 2020.
Xact Kapitalforvaltning left its Haemonetics share count unchanged in Q1 2020.
Haemonetics made up 0.02% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #535 holding.
Xact Kapitalforvaltning first reported a position in Haemonetics in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Haemonetics position peaked at $1.14M in Q2 2019.
269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.